| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/17/2001 | US6217880 Medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/17/2001 | US6217851 Mixture of calcium, arginine and bicarbonate |
| 04/17/2001 | CA2010963C Process for the preparation of lactam derivatives |
| 04/13/2001 | CA2321260A1 Oral immunology using plant product containing hepatitis surface antigen |
| 04/13/2001 | CA2320741A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025414A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | WO2001025295A1 Crosslinked copolymers based on non-crosslinked polycarboxylic copolymers |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025266A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025233A1 Piperidine derivatives |
| 04/12/2001 | WO2001025228A1 Amine derivatives |
| 04/12/2001 | WO2001025219A2 Piperazine compounds |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001025186A1 Novel ltb4 antagonist, method for the production thereof and its use as a medicament |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024813A1 Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 04/12/2001 | WO2001024812A1 USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA |
| 04/12/2001 | WO2001024795A1 RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
| 04/12/2001 | WO2001024793A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | WO2001024785A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 04/12/2001 | WO2001024780A2 Soft gel capsule resistant to gastric juices |
| 04/12/2001 | WO2001024778A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001000230A8 Drug composition containing lecithin-modified superoxide dismutase |
| 04/12/2001 | WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO2000056316A8 Treatment of gallstones |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO2000004891A3 Anti-ulcer composition |
| 04/12/2001 | DE19948428A1 Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel New LTB¶4¶ antagonist, process for its preparation and its use as a medicament |
| 04/12/2001 | DE19943634A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2387288A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386517A1 Amine derivatives |
| 04/12/2001 | CA2386461A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386277A1 An improved pharmaceutical composition and a process for its preparation |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385696A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090105A1 Ependymal neural stem cells and method for their isolation |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089753A2 Use of a dipeptide for stimulating repair processes |
| 04/11/2001 | EP1089740A1 TREATMENT OF $i(C. DIFFICILE) TOXIN B ASSOCIATED CONDITIONS |
| 04/11/2001 | EP1089733A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 04/11/2001 | EP1089724A1 Therapeutic compositions and methods of use |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP1089717A2 Chewable oral unit dosage |
| 04/11/2001 | EP0984963B1 Novel compounds |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291104A A pharmaceutical preparation comprising an angiotension II2 type receptor agonist, and use thereof |
| 04/11/2001 | CN1291099A Heterocyclic compounds, their, production and use |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1290553A Capsule for tonifying kidney |
| 04/11/2001 | CN1290546A Medicine for curing oral and throat deseases and its preparation |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/11/2001 | CN1064349C Novel tricyclic amide, its preparing method and medicinal composition |
| 04/11/2001 | CN1064262C Digestive appetitive assimilation-promoting Chinese medicine preparation |
| 04/11/2001 | CN1064260C Medicine for curing icterohepatitis A |
| 04/11/2001 | CN1064254C Application of tea pigments in preparation of medicine for curing oral submucosa fibrous disease |
| 04/11/2001 | CN1064235C Pharmaceutical application of glucoside A and B of auricledleaf swallowoft |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214858 Caspases and apoptosis |
| 04/10/2001 | US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214846 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214839 Substituted 6-alkylphenanthridines |
| 04/10/2001 | US6214830 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/10/2001 | US6214817 Nitrogen macrocycle complexes with manganese and iron |